knowledge -WSS

knowledge

author：explore 2025-09-27 13:03:31 - browse：3334

Light hits on the portrait of George Washington on a one dollar bill. The portrait is surrounded by white and red tablets coming out of a pill bottle, as well as some coins — coverage from STAT — Adobe

WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program from being able to negotiate prices for their products, including suing the government. Experts say their efforts might actually benefit Biden by reminding voters that he’s taking on big drug companies.

When Democrats passed a law directing Medicare to negotiate drug prices, it was considered a major achievement. The new law, two decades in the making, gives Biden an accomplishment to both tout for himself and criticize Republicans for opposing — no Republicans voted to let Medicare negotiate drug prices.

Medicare price negotiation is popular with voters, as are the law’s price-inflation limits, and it includes additional, direct benefits for older adults that are easy to understand. It caps annual out-of-pocket retail-drug spending for seniors and people with disabilities, and it caps their monthly spending on insulin at $35.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Ohio train derailment: Experts on toxic chemical risks

entertainment

Wikipedia

WSS

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

NEJM study measures Covid brain fog, impact on IQ

Change Healthcare cyberattack shows risk of industry consolidation

Medicare isn't yet testing food as medicine

Change Healthcare cyberattack shows risk of industry consolidation

Virtual repurposing can help discover new uses for existing drugs

leisure time

knowledge

focus

What does generative AI mean for health care? We asked experts

Color Health wants to make cancer screenings convenient

DIEP, the 'gold standard' of breast reconstruction, is under threat

Redefining sustainability for the pharmaceutical industry

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Update the Apgar Score to remove skin color

In age of alternative facts, a scholarly course on calling out crap

Redefining sustainability for the pharmaceutical industry

Anesthesiologist group: stop taking Ozempic before surgery

Immunocompromised patients offer clues on chronic Covid

Wikipedia

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Cholera vaccine supplies dangerously low, outbreaks surging

TikTok, Instagram influencers need more rules for drug ads

STAT Madness 2024: Meet the contenders

Maisha Meds is a PBM, but don't call it that

Cholera vaccine supplies dangerously low, outbreaks surging

Wikipedia

entertainment

Wikipedia

explore